Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The association between antibiotic use and risk of cancer development is unclear, and clinical trials are lacking. We performed a systematic review and meta-analysis of observational studies to assess the association between antibiotic use and risk of cancer. PubMed, the Cochrane Library and EMBASE were searched from inception to 24 February 2019 for studies reporting antibiotic use and subsequent risk of cancer. We included observational studies of adult subjects with previous exposure to antibiotics and available information on incident cancer diagnoses. For each of the eligible studies, data were collected by three reviewers. Risk of cancer was pooled to provide an adjusted odds ratio (OR) with a 95% confidence interval (CI). The primary outcome was the risk of developing cancer in ever versus non-antibiotic users. Cancer risk’s association with antibiotic intake was evaluated among 7,947,270 participants (n = 25 studies). Overall, antibiotic use was an independent risk factor for cancer occurrence (OR 1.18, 95%CI 1.12–1.24, p < 0.001). The risk was especially increased for lung cancer (OR 1.29, 95%CI 1.03–1.61, p = 0.02), lymphomas (OR 1.31, 95%CI 1.13–1.51, p < 0.001), pancreatic cancer (OR 1.28, 95%CI 1.04–1.57, p = 0.019), renal cell carcinoma (OR 1.28, 95%CI 1.1–1.5, p = 0.001), and multiple myeloma (OR 1.36, 95%CI 1.18–1.56, p < 0.001). There is moderate evidence that excessive or prolonged use of antibiotics during a person’s life is associated with slight increased risk of various cancers. The message is potentially important for public health policies because minimizing improper antibiotic use within a program of antibiotic stewardship could also reduce cancer incidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488 · cited 1×
“Similarly, the response to immune checkpoint inhibitors relies on the gut microbiota’s composition, and in patients treated with antibiotics during immunotherapy, clinical outcomes are consistently worse [38,39].”
BackgroundRinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G. A. D., Gasbarrini, A., & Mele, M. C. (2019) · Microorganisms · doi:10.3390/microorganisms7010014 · Cited by 3,462 · cited 1×
“Dysbiosis of gut microbiota is associated not only with intestinal disorders but also with numerous extra-intestinal diseases such as metabolic and neurological disorders [2], particularly when antibiotics are taken during the early years of life.”
BackgroundDethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012) · The ISME Journal · doi:10.1038/ismej.2011.109 · Cited by 1,287 · cited 1×
“For example, structural fecal bacterial distinction between colorectal cancer (CRC) patients and healthy volunteers have been demonstrated [3].”
BackgroundAntibiotic-Induced Changes in the Intestinal Microbiota and Disease
Becattini, S., Taur, Y., & Pamer, E. G. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.04.003 · Cited by 901 · cited 1×
“Antibiotic exposure, even for short periods and especially during infancy, has long-lasting effects on the microbiota, which may predispose the host to a variety of chronic diseases including cancer [5,6].”
BackgroundAnticancer effects of the microbiome and its products
Zitvogel, L., Daillère, R., Roberti, M. P., Routy, B., & Kroemer, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.44 · Cited by 538
Research works printed but not linked: 44
- Blaser, 2016, Antibiotic use and its consequences for the normal microbiome, Science, 352, 544, 10.1126/science.aad9358 · DOI · Paper page
- Ubeda, 2012, Antibiotics, microbiota, and immune defense, Trends Immunol., 33, 459, 10.1016/j.it.2012.05.003 · DOI · Paper page
- Stroup, 2000, Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
- Akre, 2000, Risk for gastric cancer after antibiotic prophylaxis in patients undergoing hip replacement, Cancer Res., 60, 6376
- Boursi, 2015, Recurrent antibiotic exposure may promote cancer formation--Another step in understanding the role of the human microbiota?, Eur. J. Cancer, 51, 2655, 10.1016/j.ejca.2015.08.015 · DOI · Paper page
- Tamim, 2008, Risk of breast cancer in relation to antibiotic use, Pharmacoepidemiol. Drug Saf., 17, 144, 10.1002/pds.1512 · doi:10.1002/pds.1512
- Boursi, 2015, Impact of antibiotic exposure on the risk of colorectal cancer, Pharmacoepidemiol. Drug Saf., 24, 534, 10.1002/pds.3765 · DOI · Paper page
- Busby, 2017, The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: A nested case-control study of routine Scottish data, Int. J. Cancer, 140, 1828, 10.1002/ijc.30612 · DOI
- Chang, 2005, Medication use and risk of non-Hodgkin’s lymphoma, Am. J. Epidemiol., 162, 965, 10.1093/aje/kwi311 · DOI
- Daniels, N.A., Chen, Y.H., and Bent, S. (2009). Antibiotic and anti-inflammatory use and the risk of prostate cancer. BMC Res. Notes, 2. · doi:10.1186/1756-0500-2-57
- Dik, 2016, Frequent Use of Antibiotics Is Associated with Colorectal Cancer Risk: Results of a Nested Case-Control Study, Dig. Dis. Sci., 61, 255, 10.1007/s10620-015-3828-0 · DOI
- Fall, 2006, Antibiotic treatment and risk of gastric cancer, Gut, 55, 793, 10.1136/gut.2006.091850 · doi:10.1136/gut.2006.091850
- Friedman, 2006, Antibiotics and risk of breast cancer: Up to 9 years of follow-up of 2.1 million women, Cancer Epidemiol. Biomark. Prev., 15, 2102, 10.1158/1055-9965.EPI-06-0401 · DOI · Paper page
- 2005, Use of antibiotics and risk of breast cancer, Am. J. Epidemiol., 161, 616, 10.1093/aje/kwi087 · DOI
- Kato, 2003, History of antibiotic use and risk of non-Hodgkin’s lymphoma (NHL), Int. J. Cancer, 107, 99, 10.1002/ijc.11356 · DOI
- Kaye, 2005, Antibiotics and the risk of breast cancer, Epidemiology, 16, 688, 10.1097/01.ede.0000172131.84877.42 · DOI
- Kilkkinen, 2008, Antibiotic use predicts an increased risk of cancer, Int. J. Cancer, 123, 2152, 10.1002/ijc.23622 · DOI · Paper page
- Rasmussen, 2012, Antibiotic use and risk of non-Hodgkin lymphomas, Int. J. Cancer, 131, E1158, 10.1002/ijc.27626 · doi:10.1002/ijc.27626
- Russell, B., Garmo, H., Beckmann, K., Stattin, P., Adolfsson, J., and Van Hemelrijck, M. (2018). A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0. PLoS ONE, 13. · doi:10.1371/journal.pone.0195690
- Tamim, 2011, Antibiotic use and risk of gynecological cancer, Eur. J. Obstet. Gynecol. Reprod. Biol., 159, 388, 10.1016/j.ejogrb.2011.06.018 · DOI
- Velicer, 2004, Antibiotic use in relation to the risk of breast cancer, JAMA, 291, 827, 10.1001/jama.291.7.827 · DOI · Paper page
- Sorensen, 2005, Use of antibiotics and risk of breast cancer: A population-based case-control study, Br. J. Cancer, 92, 594, 10.1038/sj.bjc.6602313 · DOI
- Yang, 2016, Associations of antibiotic use with risk of primary liver cancer in the Clinical Practice Research Datalink, Br. J. Cancer, 115, 85, 10.1038/bjc.2016.148 · DOI
- Zhang, 2008, Antibiotic use and the risk of lung cancer, Cancer Epidemiol. Biomark. Prev., 17, 1308, 10.1158/1055-9965.EPI-07-2817 · DOI
- Tamim, 2010, Association between antibiotic use and risk of prostate cancer, Int. J. Cancer, 127, 952, 10.1002/ijc.25139 · DOI
- Didham, 2005, Antibiotic exposure and breast cancer in New Zealand, Breast Cancer Res. Treat., 92, 163, 10.1007/s10549-005-2115-8 · doi:10.1007/s10549-005-2115-8
- Wang, 2014, Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case-control study in patients with Type 2 diabetes mellitus, Int. J. Cancer, 135, 956, 10.1002/ijc.28738 · DOI · Paper page
- Knekt, 2000, Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer?, Br. J. Cancer, 82, 1107, 10.1054/bjoc.1999.1047 · DOI
- Yang, 2017, Antibiotic-Induced Changes to the Host Metabolic Environment Inhibit Drug Efficacy and Alter Immune Function, Cell Host Microbe, 22, 757, 10.1016/j.chom.2017.10.020 · DOI · Paper page
- Sergentanis, 2010, Is antibiotic use a risk factor for breast cancer? A meta-analysis, Pharmacoepidemiol. Drug Saf., 19, 1101, 10.1002/pds.1986 · DOI
- Khosravi, 2013, Disruption of the gut microbiome as a risk factor for microbial infections, Curr. Opin. Microbiol., 16, 221, 10.1016/j.mib.2013.03.009 · DOI · Paper page
- Aragon, 2018, The Urinary Tract Microbiome in Health and Disease, Eur. Urol. Focus, 4, 128, 10.1016/j.euf.2016.11.001 · DOI · Paper page
- Mao, 2018, Interplay between the lung microbiome and lung cancer, Cancer Lett., 415, 40, 10.1016/j.canlet.2017.11.036 · DOI · Paper page
- Whiteside, 2015, The microbiome of the urinary tract—A role beyond infection, Nat. Rev. Urol., 12, 81, 10.1038/nrurol.2014.361 · DOI · Paper page
- Yamamoto, 2014, Intestinal microbiome and lymphoma development, Cancer J., 20, 190, 10.1097/PPO.0000000000000047 · DOI
- Mima, 2017, The microbiome and hepatobiliary-pancreatic cancers, Cancer Lett., 402, 9, 10.1016/j.canlet.2017.05.001 · DOI
- Zhu, 2016, Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-Analysis, Medicine, 95, e3077, 10.1097/MD.0000000000003077 · DOI · Paper page
- Langdon, 2016, The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation, Genome Med., 8, 39, 10.1186/s13073-016-0294-z · DOI · Paper page
- Durand, 2005, Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge, J. Clin. Microbiol., 43, 5588, 10.1128/JCM.43.11.5588-5592.2005 · DOI · Paper page
- Fasugba, O., Gardner, A., Mitchell, B.G., and Mnatzaganian, G. (2015). Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: A systematic review and meta-analysis of observational studies. BMC Infect. Dis., 15. · DOI · Paper page
- Park, 2018, Intestinal microbiota, chronic inflammation, and colorectal cancer, Intest. Res., 16, 338, 10.5217/ir.2018.16.3.338 · DOI
- Meeker, 2016, Effect of Behavioral Interventions on Inappropriate Antibiotic Prescribing Among Primary Care Practices: A Randomized Clinical Trial, JAMA, 315, 562, 10.1001/jama.2016.0275 · DOI · Paper page
- Sikkens, 2017, Behavioral Approach to Appropriate Antimicrobial Prescribing in Hospitals: The Dutch Unique Method for Antimicrobial Stewardship (DUMAS) Participatory Intervention Study, JAMA Intern. Med., 177, 1130, 10.1001/jamainternmed.2017.0946 · DOI
Cited by
Is early-onset cancer an emerging global epidemic? Current evidence and future implications
Ugai, T., Sasamoto, N., Lee, H.-Y., Ando, M., Song, M., Tamimi, R. M., Kawachi, I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., et al. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00672-8 · Cited by 603
(2021) · doi:10.3322/caac.21697 · Cited by 201
Guillot, N., Roméo, B., Manesh, S. S., Milano, G., Brest, P., Zitvogel, L., Hofman, P., & Mograbi, B. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.004 · Cited by 36
Hung, Y.-P., Lee, C.-C., & Ko, W.-C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.869822 · Cited by 29
Association of midlife antibiotic use with subsequent cognitive function in women
Mehta, R. S., Lochhead, P., Wang, Y., Ma, W., Nguyen, L. H., Kochar, B., Huttenhower, C., Grodstein, F., & Chan, A. T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264649 · Cited by 26
“Chronic antibiotic use has been associated with an increased risk of conditions related to chronic inflammation, including obesity [10], cancer [11], and colonic neoplasia [12].”
Background
Metadata
- Authors
- Petrelli, F., Ghidini, M., Ghidini, A., Perego, G., Cabiddu, M., Khakoo, S., Oggionni, E., Abeni, C., Hahne, J. C., Tomasello, G., & Zaniboni, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-08-14
- Volume
- 11
- Issue
- 8
- Pages
- 1174
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2967544221
- Cited by
- 106
- References
- 9
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies. https://app.cochat.ai/papers/10.3390/cancers11081174
- The paper
- Petrelli, F., Ghidini, M., Ghidini, A., Perego, G., Cabiddu, M., Khakoo, S., Oggionni, E., Abeni, C., Hahne, J. C., Tomasello, G., & Zaniboni, A. (2019). Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Cancers. https://doi.org/10.3390/cancers11081174
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.